Published in J Biol Chem on December 15, 2000
Advances in early kidney specification, development and patterning. Development (2009) 2.62
Glial cell line-derived neurotrophic factor regulation of genes essential for self-renewal of mouse spermatogonial stem cells is dependent on Src family kinase signaling. J Biol Chem (2007) 1.98
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. J Med Genet (2004) 1.85
PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice. J Clin Invest (2010) 1.66
Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol (2002) 1.64
Gdnf upregulates c-Fos transcription via the Ras/Erk1/2 pathway to promote mouse spermatogonial stem cell proliferation. Stem Cells (2007) 1.61
Critical and distinct roles for key RET tyrosine docking sites in renal development. Genes Dev (2006) 1.54
Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J Cell Biol (2001) 1.52
Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis. Genes Dev (2001) 1.51
Role of Src family kinases and N-Myc in spermatogonial stem cell proliferation. Dev Biol (2006) 1.44
A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia. Mol Cell Biol (2004) 1.44
Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol Cell Biol (2001) 1.29
Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform. Mol Cell Biol (2005) 1.23
Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation. J Med Genet (2007) 1.18
PTEN modulates GDNF/RET mediated chemotaxis and branching morphogenesis in the developing kidney. Dev Biol (2007) 1.12
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. Cancer Res (2009) 1.11
Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption. J Neurosci (2005) 1.07
The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. Mol Cell Biol (2002) 1.06
A Drosophila model of multiple endocrine neoplasia type 2. Genetics (2005) 1.03
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction. J Natl Cancer Inst (2013) 0.98
Effects of cerebral ischemia in mice deficient in Persephin. Proc Natl Acad Sci U S A (2002) 0.98
Analysis of Ret knockin mice reveals a critical role for IKKs, but not PI 3-K, in neurotrophic factor-induced survival of sympathetic neurons. Cell Death Differ (2008) 0.95
Organotypic specificity of key RET adaptor-docking sites in the pathogenesis of neurocristopathies and renal malformations in mice. J Clin Invest (2010) 0.95
Loss of Sprouty1 rescues renal agenesis caused by Ret mutation. J Am Soc Nephrol (2008) 0.95
The neuronal scaffold protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells. J Cell Biol (2004) 0.92
The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth. EMBO J (2007) 0.91
Characterization of gene expression induced by RET with MEN2A or MEN2B mutation. Am J Pathol (2002) 0.91
Alternative splicing results in RET isoforms with distinct trafficking properties. Mol Biol Cell (2012) 0.91
Structure and physiology of the RET receptor tyrosine kinase. Cold Spring Harb Perspect Biol (2013) 0.90
Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study. J Transl Med (2014) 0.90
Rap1GAP interacts with RET and suppresses GDNF-induced neurite outgrowth. Cell Res (2010) 0.87
Regulation of the postnatal development of dopamine neurons of the substantia nigra in vivo by Akt/protein kinase B. J Neurochem (2009) 0.86
Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity. Mol Neurobiol (2013) 0.85
Angiotensin II-induced activation of c-Ret signaling is critical in ureteric bud branching morphogenesis. Mech Dev (2009) 0.84
The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis. Mol Cell Biol (2001) 0.83
Treatment modality affects allograft-derived Schwann cell phenotype and myelinating capacity. Exp Neurol (2008) 0.83
Intracellular signalling pathways in dopamine cell death and axonal degeneration. Prog Brain Res (2010) 0.83
Renin-angiotensin system in ureteric bud branching morphogenesis: insights into the mechanisms. Pediatr Nephrol (2011) 0.82
Receptor tyrosine kinases in kidney development. J Signal Transduct (2011) 0.82
Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase. J Biol Chem (2010) 0.82
Glial cell line-derived neurotrophic factor receptor-α1 expressed in striatum in trans regulates development and injury response of dopamine neurons of the substantia nigra. J Neurochem (2011) 0.81
The genetics and epigenetics of kidney development. Semin Nephrol (2013) 0.80
Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling. Neurobiol Dis (2011) 0.80
Renin-angiotensin system in ureteric bud branching morphogenesis: implications for kidney disease. Pediatr Nephrol (2013) 0.78
Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons. J Neurosci (2012) 0.76
Ret function in muscle stem cells points to tyrosine kinase inhibitor therapy for facioscapulohumeral muscular dystrophy. Elife (2016) 0.75
Exon Skipping in the RET Gene Encodes Novel Isoforms That Differentially Regulate RET Protein Signal Transduction. J Biol Chem (2016) 0.75
Brain ischemia downregulates the neuroprotective GDNF-Ret signaling by a calpain-dependent mechanism in cultured hippocampal neurons. Cell Death Dis (2015) 0.75
Ape1/Ref-1 Stimulates GDNF/GFRalpha1-mediated Downstream Signaling and Neuroblastoma Proliferation. Korean J Physiol Pharmacol (2009) 0.75
Resistance to RET-inhibition in RET-rearranged NSCLC is mediated by reactivation of RAS/MAPK signaling. Mol Cancer Ther (2017) 0.75
The orphan receptor ALK7 and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development. Genes Dev (2001) 2.17
Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci U S A (1992) 2.14
Evolutionary studies of the nerve growth factor family reveal a novel member abundantly expressed in Xenopus ovary. Neuron (1991) 2.02
Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain. Proc Natl Acad Sci U S A (1990) 1.94
NMR structure of the death domain of the p75 neurotrophin receptor. EMBO J (1997) 1.84
Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol (1995) 1.73
Muscle-derived neurotrophin-4 as an activity-dependent trophic signal for adult motor neurons. Science (1995) 1.70
Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron (2001) 1.69
Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells. J Biol Chem (1999) 1.44
Etomidate shortens the onset time of neuromuscular block. Br J Anaesth (1992) 1.41
Reversal of prolonged suxamethonium apnoea with fresh frozen plasma in a 6-week-old infant. Anaesthesia (1991) 1.41
p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron (1994) 1.28
GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron (1995) 1.23
A novel type I receptor serine-threonine kinase predominantly expressed in the adult central nervous system. J Biol Chem (1996) 1.17
Molecular modeling of the extracellular domain of the RET receptor tyrosine kinase reveals multiple cadherin-like domains and a calcium-binding site. J Biol Chem (2001) 1.13
Cell type-specific regulation of choline acetyltransferase gene expression. Role of the neuron-restrictive silencer element and cholinergic-specific enhancer sequences. J Biol Chem (1996) 1.11
Role of brain-derived neurotrophic factor in target invasion in the gustatory system. J Neurosci (1999) 1.09
Neuromuscular junction disassembly and muscle fatigue in mice lacking neurotrophin-4. Mol Cell Neurosci (2001) 1.09
Cardiopulmonary resuscitation in a teaching hospital. A survey of cardiac arrests occurring outside intensive care units and emergency rooms. Anaesthesia (1981) 1.05
Distinct structural elements in GDNF mediate binding to GFRalpha1 and activation of the GFRalpha1-c-Ret receptor complex. EMBO J (1999) 1.05
Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations. Oncogene (2006) 1.04
Multiple GPI-anchored receptors control GDNF-dependent and independent activation of the c-Ret receptor tyrosine kinase. Mol Cell Neurosci (1998) 1.01
Functional analysis of mutant neurotrophins deficient in low-affinity binding reveals a role for p75LNGFR in NT-4 signalling. EMBO J (1995) 1.00
Differential modulation of neuron survival during development by nerve growth factor binding to the p75 neurotrophin receptor. J Biol Chem (1997) 0.99
BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex. Neuron (1998) 0.98
Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol (1993) 0.97
Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis. Br J Cancer (1996) 0.96
CRNF, a molluscan neurotrophic factor that interacts with the p75 neurotrophin receptor. Science (1996) 0.95
Early evolutionary origin of the neurotrophin receptor family. EMBO J (1998) 0.93
The orphan receptor serine/threonine kinase ALK7 signals arrest of proliferation and morphological differentiation in a neuronal cell line. J Biol Chem (2000) 0.93
The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U). A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology (1988) 0.91
Role of variable beta-hairpin loop in determining biological specificities in neurotrophin family. J Biol Chem (1994) 0.90
Role and expression of neurotrophins and the trk family of tyrosine kinase receptors in neural growth and rescue after injury. Curr Opin Neurol Neurosurg (1993) 0.90
Limb proprioceptive deficits without neuronal loss in transgenic mice overexpressing neurotrophin-3 in the developing nervous system. Development (1997) 0.89
Binding of neurotrophin-3 to p75LNGFR, TrkA, and TrkB mediated by a single functional epitope distinct from that recognized by trkC. J Biol Chem (1996) 0.89
Neurotrophin-7: a novel member of the neurotrophin family from the zebrafish. FEBS Lett (1998) 0.88
Targeted expression of a multifunctional chimeric neurotrophin in the lesioned sciatic nerve accelerates regeneration of sensory and motor axons. Proc Natl Acad Sci U S A (1998) 0.88
Evidence of parasexual exchange of DNA in the rice blast fungus challenges its exclusive clonality. Phytopathology (1997) 0.87
An automatic apparatus for the synthesis of peptides using resin coated glass beads in the form of a packed bed. J Chromatogr Sci (1972) 0.84
Adhesion of carboxylate cements to hydroxyapatite. III. Adsorption of poly(alkenoic acids). Biomaterials (1990) 0.84
A study of variables affecting the impinging jet method for measuring the erosion of dental cements. Biomaterials (1986) 0.82
Mammalian GFRalpha -4, a divergent member of the GFRalpha family of coreceptors for glial cell line-derived neurotrophic factor family ligands, is a receptor for the neurotrophic factor persephin. J Biol Chem (2000) 0.82
Recombinant human beta-nerve growth factor (NGF): biological activity and properties in an enzyme immunoassay. J Neurosci Res (1990) 0.82
Cellular localization of brain-derived neurotrophic factor and neurotrophin-3 mRNA expression in the early chicken embryo. Eur J Neurosci (1993) 0.81
Nerve growth factor: structure/function relationships. Protein Sci (1994) 0.81
Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma. Eur J Cancer (1997) 0.81
Onset times and intubating conditions. Br J Anaesth (1998) 0.81
Atracurium: clinical strategies for preventing histamine release and attenuating the haemodynamic response. Br J Anaesth (1985) 0.80
Atracurium: its speed of onset. A comparison with suxamethonium. Br J Anaesth (1982) 0.79
In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase--I. On the reactions of P2S with various organophosphates and the properties of the resultant phosphylated oximes. Biochem Pharmacol (1986) 0.79
Regulatory region in choline acetyltransferase gene directs developmental and tissue-specific expression in transgenic mice. Proc Natl Acad Sci U S A (1995) 0.79
Adhesion of carboxylate cements to hydroxyapatite. I. The effect of the structure of aliphatic carboxylates on their uptake by hydroxyapatite. Biomaterials (1986) 0.79
Evidence for free radical-mediated lipid peroxidation at reperfusion of human orthotopic liver transplants. Surgery (1994) 0.78
Isolation and characterization of cathepsin B from rabbit testis. J Reprod Fertil (1987) 0.77
Forum. A comparison between the midline and paramedian approaches to the extradural space. Anaesthesia (1984) 0.77
In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase--II. On the formation of O,O-diethyl phosphorylated AChE and O-ethyl methylphosphonylated AChE and their reactivation by PS2. Biochem Pharmacol (1986) 0.77
Use of microbore columns for the separation of substances of biological origin. J Chromatogr (1979) 0.76
The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiology (1989) 0.76
A second determinant of binding to the p75 neurotrophin receptor revealed by alanine-scanning mutagenesis of a conserved loop in nerve growth factor. J Biol Chem (1997) 0.76
Clinical observations on Org 9426. Br J Anaesth (1990) 0.75
Atracurium and histamine. Br J Anaesth (1992) 0.75
The challenges of health disparity and cardiovascular outcomes. Ann Thorac Surg (2001) 0.75
Polypeptides as a permanently bound stationary phase in liquid chromatography. Anal Chem (1973) 0.75
Novel, testis-specific mRNA transcripts encoding N-terminally truncated choline acetyltransferase. Mol Reprod Dev (1999) 0.75
Synergistic trophic actions on rat basal forebrain neurons revealed by a synthetic NGF/BDNF chimaeric molecule. Eur J Neurosci (1995) 0.75
Mivacurium chloride and myasthenia gravis. Br J Anaesth (1994) 0.75
The effects of transtracheal gas delivery on central inspiratory neuromuscular drive. Chest (1993) 0.75
Cardiac arrests in general wards: three-year follow-up. Lancet (1983) 0.75
Cardiovascular and autonomic effects of muscle relaxants. Compr Ther (1985) 0.75
High-fidelity line-by-line optical waveform generation and complete characterization using FROG. Opt Express (2007) 0.75
Recent tehniques in flavour analysis. Chem Ind (1969) 0.75
Mivacurium chloride and late onset congenital myopathy. Br J Anaesth (1996) 0.75
The response of myasthenia gravis to atracurium. Anesthesiology (1985) 0.75
Clinical pharmacology of atracurium given in high dose. Br J Anaesth (1986) 0.75
The cement-forming properties of phytic acid. J Dent Res (1983) 0.75
"New" cardiopulmonary resuscitation. Lancet (1982) 0.75
Do we need more muscle relaxants? Br J Anaesth (1988) 0.75
Women in thoracic surgery: an ancient tradition and a new milestone. Ann Thorac Surg (2000) 0.75
Researchers face 'Catch-22' grants trap. Nature (1999) 0.75
Mivacurium chloride and myotonic dystrophy. Br J Anaesth (1995) 0.75
32 Phase X 32 amplitude optical arbitrary waveform generation. Opt Lett (2007) 0.75
A problem with the Argyll tube. Anaesthesia (1987) 0.75
Human nerve growth factor: biological and immunological activities, and clinical possibilities in neurodegenerative disease. Adv Exp Med Biol (1991) 0.75
AM and high-harmonic FM laser mode locking. Appl Opt (1997) 0.75
Gas-liquid chromatography: recent developments in apparatus and technique. Br Med Bull (1966) 0.75
Recent evolutionary origin within the primate lineage of two pseudogenes with similarity to members of the transforming growth factor-beta superfamily. Cell Mol Life Sci (2004) 0.75
An evaluation of the significance of the impinging jet method for measuring the acid erosion of dental cements. Biomaterials (1986) 0.75
On the role of the low-affinity neurotrophin receptor p75LNTR in nerve growth factor induction of differentiation and AP 1 binding activity in PC12 cells. J Mol Neurosci (1997) 0.75